Individual Investigator Research Grant

0 Saves · 2 Shares · 1 Comments Discussion

Grant Name

Funder

Foundation Fighting Blindness (FFB)

Country or Region

United States

Research Field

Bioengineering

Blindness

Clinical Research or Studies

Clinical Trials

Eye Diseases

Gene Therapy

Genetic Disorders

Medical Genetics

Medical Treatment

Mutation

Ophthalmology

Organ Transplantation

Orphan Rare Diseases

Vision

Visual Perception

Visual Prostheses

Deadline

November 11, 2021 (Expired)

Grant Size

Upper $300,000USD Lower $100,000USD The award will be approximately $100,000 per year up to three years. The award may be used to support the salaries of research trainees (graduate students, postdoctoral or clinical fellows), technical staff and research supplies. Partial support for the Principal Investigator's salary is permitted but is not to exceed 20% of the total annual award.

Contact Info

Fighting Blindness Foundation grants@fightblindness.org

Eligibility

Applicants must hold a Ph.D., M.D., D.M.D., D.V.M., D.O., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory.

Description

Individual Investigator Research Grant Awards are designed to concentrate research in areas that will have the greatest potential to move towards treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration (dAMD). N.B.: FFB does not support research for neovascular AMD or diabetic retinopathy. The Foundation has identified Research Priority Areas (RPA) that align with its mission and this targeted open call for application is to address specific gaps identified in current retinal disease research. While applications addressing the areas of particular interest below will be given priority consideration, the FFB will also consider proposals for highly novel research that do not fit easily within these goals The LOI for such proposals must clearly explain why the research is likely to lead to prevention, treatments or cures for the orphan inherited retinal degenerative diseases. RESEARCH PRIORITY AREAS (RPA): - Novel Medical Therapies (NMT) - Gene Therapy (GT) - Cell and Molecular Mechanisms of Retinal Disease (CMM) - Genetics (GE) - Clinical-Structure and Function (CL) - Regenerative Medicine (RM) Eligibility Applicants must hold a Ph.D., M.D., D.M.D., D.V.M., D.O., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory.

Website

http://www.blindness.org/apply-for-funding#iirg

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link